Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity

por Yuan, Z, Syrkin, G, Adem, A, Geha, R, Pastoriza, J, Vrikshajanani, C, Smith, T, Quinn, T J, Alemu, G, Cho, H, Barrett, C J, Arap, W, Pasqualini, R, Libutti, S K
Publicado 2013